Ponoi Ii Management, LLC Rapt Therapeutics, Inc. Transaction History
Ponoi Ii Management, LLC
- $38.3 Million
- Q3 2022
A detailed history of Ponoi Ii Management, LLC transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Ponoi Ii Management, LLC holds 145,401 shares of RAPT stock, worth $4.23 Million. This represents 9.14% of its overall portfolio holdings.
Number of Shares
145,401
Previous 145,401
-0.0%
Holding current value
$4.23 Million
Previous $2.65 Million
31.8%
% of portfolio
9.14%
Previous 7.21%
Shares
1 transactions
Others Institutions Holding RAPT
# of Institutions
13Shares Held
6.5MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY2.44MShares$71 Million0.0% of portfolio
-
Ponoi Management, LLC San Francisco, CA1.6MShares$46.5 Million52.54% of portfolio
-
Column Group LLC San Francisco, CA1.33MShares$38.7 Million16.17% of portfolio
-
Kpcb Xv Associates, LLC649KShares$18.9 Million43.54% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL117KShares$3.4 Million0.0% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $863M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...